Alzheimer's disease image classification based on enhanced residual attention network.
Where this comes from
- Record sourced from PubMed, PMID 39869613.
- Also identified by DOI 10.1371/journal.pone.0317376 and PMC identifier 11771898.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
With the increasing number of patients with Alzheimer's Disease (AD), the demand for early diagnosis and intervention is becoming increasingly urgent. The traditional detection methods for Alzheimer's disease mainly rely on clinical symptoms, biomarkers, and imaging examinations. However, these methods have limitations in the early detection of Alzheimer's disease, such as strong subjectivity in diagnostic criteria, high detection costs, and high misdiagnosis rates. To address these issues, this study proposes a deep learning model to detect Alzheimer's disease; it is called Enhanced Residual Attention Network (ERAN) that can classify medical images. By combining residual learning, attention mechanism, and soft thresholding, the feature representation ability and classification accuracy of the model have been improved. The accuracy of the model in detecting Alzheimer's disease has reached 99.36%, with a loss rate of only 0.0264. The experimental results indicate that the Enhanced Residual Attention Network has achieved excellent performance on the Alzheimer's disease test dataset, providing strong support for the early diagnosis and treatment of Alzheimer's disease.
Medical subject headings
- Alzheimer Disease
- Image Interpretation, Computer-Assisted